Aurora to Participate in the TD Cowen 46th Annual Health Care Conference

Aurora (NASDAQ: ACB) will participate in the TD Cowen 46th Annual Health Care Conference on March 2, 2026.

Rhea-AI Summary

Aurora (NASDAQ: ACB) will participate in the TD Cowen 46th Annual Health Care Conference on March 2, 2026. CFO Simona King will join a fireside chat and investor meetings to discuss international leadership and manufacturing trends in medical cannabis.

Webcast registration is available on the company's Investor Info page and a replay will be accessible for approximately 90 days. The company also announced completion of the previously disclosed Bevo transaction dated February 4, 2026.

Argus Feb 18 session

-1.39% close to close Open Argus

Details

News Market Reaction – ACB

On Feb 18, the first trading day after this news, ACB closed 1.39% below the previous close.

Data tracked by StockTitan Argus for the Feb 18 session.

Market Context

This announcement highlights Aurora’s continued investor-relations engagement and operational reshap...

Analysis

This announcement highlights Aurora’s continued investor-relations engagement and operational reshaping. Participation in TD Cowen’s conference on March 2, 2026 offers a platform to discuss global medical strategy, while completion of the Bevo transaction follows through on previously outlined restructuring steps. In context of recent earnings, ATM program, and international product launches, investors may watch for updated commentary on capital allocation, medical cannabis growth trends, and how Bevo-related changes affect Aurora’s financial profile and strategic focus.

Key Figures

Conference edition: 46th Annual Conference date: March 2, 2026 Conference time ET: 11:10 a.m. +5 more

Conference edition

46th Annual

TD Cowen Health Care Conference

Conference date

March 2, 2026

TD Cowen Health Care Conference participation

Conference time ET

11:10 a.m.

Fireside chat start time Eastern Time

Conference time MT

9:10 a.m.

Fireside chat start time Mountain Time

Webcast replay duration

90 days

Replay availability for conference fireside chat

Bevo prior announcement date

February 4, 2026

Reference date for prior Bevo transaction press release

Price change

1.41%

ACB price change over last 24 hours before this news

52-week high discount

46.79%

Price vs 52-week high before this news

Historical Context

5 past events · Latest: Feb 12

5 events

1. Feb 12

   IR / branding

   24h Move

   -2.3%

   Nasdaq closing bell ceremony to spotlight global medical cannabis strategy.

2. Feb 11

   Intl expansion

   24h Move

   -3.4%

   Launch of new THC flower and resin products in Australia and New Zealand.

3. Feb 04

   ATM offering

   24h Move

   -7.6%

   Prospectus supplement for at-the-market program up to US$100M common shares.

4. Feb 04

   Earnings update

   24h Move

   -7.6%

   Q3 FY2026 results with higher revenue, positive EBITDA and reaffirmed guidance.

5. Feb 03

   Digital expansion

   24h Move

   +3.6%

   Launch of localized European medical websites and central hub auroramedicine.com.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NASDAQ | TSX: ACB

Canada's Largest Global Medical Cannabis Company to Discuss Growth Strategy, Key Trends and Market Opportunities

EDMONTON, AB, Feb. 17, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, will participate in TD Cowen's 46th Annual Health Care Conference in Boston, MA. Simona King, Chief Financial Officer at Aurora, will take part in a fireside chat and one-on-one meetings with investors on March 2, 2026.

Conference Details

DATE: Monday, March 2, 2026

TIME: 11:10am Eastern Time | 9:10am Mountain Time

WEBCAST: Click Here

The fireside chat will be hosted by Derek Lessard, VP of Equity Research at TD Cowen. The discussion will explore Aurora's international leadership, shifts reshaping the global medical cannabis landscape, advancements in Canadian manufacturing excellence, and the broader market forces influencing the industry's growth.

To listen to the live audio webcast, please register using the weblink above, which has also been posted to the Company's "Investor Info" section at https://www.auroramj.com/investors/ under "Events". A replay of the presentation will be available using the same link for approximately 90 days.

Further, the Company announces that it has completed the transaction with Bevo Agtech Inc. ("Bevo"), previously announced on February 4, 2026 (the "Bevo Transaction"). Full details of the Bevo Transaction can be found in the February 4, 2026 press release located under the Company's profile at www.sedarplus.ca.

About Aurora 

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance, and a deep commitment to patient care. Aurora serves both medical and consumer markets across Canada, Europe, Australia, and New Zealand, with a strategic focus on high-margin opportunities and a medical-first approach. Aurora's portfolio of trusted, leading brands includes Aurora^®, MedReleaf^®, Pedanios^®, IndiMed™, San Raf^®, Tasty's^® and Whistler Medical Marijuana Co.^®. With world-class GMP-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of Opening the World to Cannabis™.

Learn more at www.auroramj.com and follow us on X and LinkedIn. 

Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".

Forward Looking Information

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the Company's upcoming participation at the TD Cowen 46th Annual Health Care Conference, as well as those related to the Company's global medical cannabis market leadership.

These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the magnitude and duration of potential new or increased tariffs imposed on goods imported from Canada into the United States; the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information from dated June 17, 2025 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at www.sedarplus.com and filed with and available on the SEC's website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/aurora-to-participate-in-the-td-cowen-46th-annual-health-care-conference-302691035.html

SOURCE Aurora Cannabis Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Aurora (ACB) present at the TD Cowen Health Care Conference in 2026?

Aurora will present on March 2, 2026 at 11:10am Eastern Time in a fireside chat. According to the company, CFO Simona King will participate and hold one-on-one investor meetings during that date.

How can investors watch Aurora's (ACB) March 2, 2026 fireside chat at TD Cowen?

Investors can listen via a live audio webcast by registering through the company's Investor Info events link. According to the company, a replay will be available at the same link for about 90 days after the event.

Who will host Aurora's (ACB) fireside chat at the TD Cowen conference?

The fireside chat will be hosted by Derek Lessard, VP of Equity Research at TD Cowen. According to the company, the discussion will cover international leadership and Canadian manufacturing advancements.

What topics will Aurora (ACB) cover in its TD Cowen conference presentation?

Aurora will discuss international leadership, shifts in the medical cannabis landscape, and Canadian manufacturing excellence. According to the company, the session will explore market forces shaping industry growth.

Did Aurora (ACB) complete the Bevo transaction mentioned in February 2026?

Yes, the company announced completion of the previously disclosed transaction with Bevo Agtech Inc. on February 17, 2026. According to the company, full transaction details are available in the February 4, 2026 release on SEDAR+.